Silverfin false false 31/03/2026 31/03/2026 01/04/2025 no description of principal activity Dr Marcus Rauch 05/03/2018 Dr Angelique Van 'T Wout 29/07/2018 Dr Robert Williamson 05/03/2018 11232306 2026-03-31 11232306 bus:Director1 2026-03-31 11232306 bus:Director2 2026-03-31 11232306 bus:Director3 2026-03-31 11232306 2025-03-31 11232306 core:CurrentFinancialInstruments 2026-03-31 11232306 core:CurrentFinancialInstruments 2025-03-31 11232306 2025-04-01 2026-03-31 11232306 bus:Micro-entities 2025-04-01 2026-03-31 11232306 bus:AbridgedAccounts 2025-04-01 2026-03-31 11232306 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 11232306 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11232306 bus:Director1 2025-04-01 2026-03-31 11232306 bus:Director2 2025-04-01 2026-03-31 11232306 bus:Director3 2025-04-01 2026-03-31 11232306 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 11232306 (England and Wales)

ALPHABIOMICS LTD

Abridged Unaudited Financial Statements
For the financial year ended 31 March 2026

ALPHABIOMICS LTD

ABRIDGED UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 March 2026

Contents

ALPHABIOMICS LTD

COMPANY INFORMATION

For the financial year ended 31 March 2026
ALPHABIOMICS LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2026
DIRECTORS Dr Marcus Rauch
Dr Angelique Van 'T Wout
Dr Robert Williamson
REGISTERED OFFICE 4 Queensway
Ponteland
Newcastle Upon Tyne
NE20 9RZ
United Kingdom
COMPANY NUMBER 11232306 (England and Wales)
ACCOUNTANT Synergee
Pluto House
6 Vale Avenue
Tunbridge Wells
TN1 1DJ
ALPHABIOMICS LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2026
ALPHABIOMICS LTD

STATEMENT OF FINANCIAL POSITION (continued)

For the financial year ended 31 March 2026
31.03.2026 31.03.2025
£ £
Fixed assets 495 1,089
Current assets 11,830 13,080
Prepayments and accrued income - 108
Creditors: amounts falling due within one year ( 144) ( 17,897)
Net current assets/(liabilities) 11,686 ( 4,709)
Total assets less current liabilities 12,181 ( 3,620)
Accruals and deferred income ( 16,105) ( 850)
Net liabilities ( 3,924) ( 4,470)
Capital and reserves ( 3,924) ( 4,470)

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of AlphaBiomics Ltd (registered number: 11232306) were approved and authorised for issue by the Board of Directors on 19 May 2026 and were signed on its behalf by:

Dr Angelique Van 'T Wout
Director
ALPHABIOMICS LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

For the financial year ended 31 March 2026
ALPHABIOMICS LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 March 2026

1. Employees

31.03.2026 31.03.2025
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors - 0